ABL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abbott Laboratories

Watchlist Manager

Watchlist

Price: 92.42 EUR 2.1% Market Closed

Market Cap: €160.8B

A	Abbott Laboratories XETRA:ABL	US
P	Paychex Inc F:PCX	US
C	Conocophillips F:YCP	US
B	British American Tobacco PLC F:BMT	UK
A	AstraZeneca PLC NASDAQ:AZN	UK
J	JPMorgan Chase & Co XMUN:CMC	US
	Comcast Corp NASDAQ:CMCSV	US
S	Schneider Electric SE XBER:SND	FR
	Monster Beverage Corp NASDAQ:MNST	US
P	Progressive Corp SWB:PGV	US
	Equifax Inc NYSE:EFX	US
H	Henkel AG & Co KGaA DUS:HEN	DE
	Sappi Ltd OTC:SPPJY	ZA
Y	Yeti Holdings Inc F:1YN	US
V	Vanquis Banking Group PLC DUS:PRVA	UK

Profitability Summary

Abbott Laboratories's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

56%

Gross Margin is Increasing

55% > 57%

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

16% > 17%

Healthy Net Margin

12%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

13% > 12%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

14% > 16%

Positive ROE

11%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

Declining ROIC

9% > 7%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.